Img 2179edited Fixed Lab Coat

Retina Foundation 20/20 Video Research Updates

The Retina Foundation is pleased to share 20/20 video updates as we continue to move forward with our cutting-edge research, reading, planning experiments, analyzing data, and drafting new grant proposals as we telecommute. Introduction Video by Dr. Karl Csaky, CEO …

Drew Brees Cropped

Join Drew Brees and the Retina Foundation for the Third Annual Visionary Luncheon – March 4, 2020

Drew Brees, Super Bowl-winning quarterback for the New Orleans Saints and Texas native, will be the featured speaker for the 2020 Visionary Luncheon benefiting the Retina Foundation of the Southwest on Wednesday, March 4, 2020. As much pride as Brees takes in …

Img 1764

Promising results from ongoing Phase 1/2 clinical trial for X-linked retinitis pigmentosa (XLRP)

October 1, 2019 The Retina Foundation of the Southwest is one of four U.S. centers conducting a Phase 1/2 dose escalation, gene replacement trial for x-linked retinitis pigmentosa (XLRP). On September 26th, the clinical trial sponsor, Applied Genetic Technologies Corporation …

2019retinafdn 248

The Effectiveness of Therapeutic Drugs for AMD in the Laboratory

September 26, 2019 Ruvanthi Kularatne, Ph.D., is a Postdoctoral Fellow at the Retina Foundation of the Southwest, working under the direction of Karl Csaky, M.D., Ph.D., Managing & Medical Director. Dr. Kularatne has spent the past year evaluating the effectiveness …

Retina01large Copy

Introducing the Vision and Neurodevelopment Laboratory

August 15, 2019 We are pleased to announce Krista Kelly, Ph.D. as Director of the Vision and Neurodevelopment Laboratory! Dr. Krista Kelly received her Ph.D. from York University in 2014 before joining the Retina Foundation of the Southwest as a …

2019retinafdn 068

Measuring the Release of A Therapeutic Drug in a Controlled Lab Setting

August 2, 2019 Age-related macular degeneration (AMD) has multiple stages of progression. The “dry” form is characterized by yellow deposits called drusen, that grow in size and number, leading to dimmed or distorted vision. There are currently no treatments for …

2019retinafdn 659 Eye Chart

Retina Foundation Asks Kids to ‘Just Dance’ for Research Study

July 31, 2019 The Retina Foundation is an international leader in research on lazy eye, the most common cause of visual impairment in children. A new treatment we are working on in collaboration with Mayo Clinic has the goal of …

Gene Therapy

Gene Therapy Trial for Choroideremia

July 23, 2019 In a clinical research study headed by Dr. David Birch, scientists in the Rose-Silverthorne Retinal Degenerations Lab are testing the efficacy of gene therapy in patients with choroideremia. This late stage trial is based on early Phase …

2019retinafdn 479 (reduced)

FFB Pledges $300,000 to Support Dr. Yi-Zhong Wang’s Artificial Intelligence/ Deep Machine Learning Project

July 19, 2019 Yi-Zhong Wang, Ph.D., Scientific Director, Macular Function Laboratory, is working to achieve automatic and accurate identification of defects in the structure of patients’ retinas by applying deep machine learning method. Over the past year, using a cutting-edge …

Jenny Schisler Photo

What Does “Blindness” Really Mean?

May 20, 2019 Jenny Schisler has retinitis pigmentosa. Jenny wants to spread awareness of what having a visual impairment really means to her and others affected by retinal degenerative diseases. By Jenny Schisler There was recently a viral image of …

2019retinafdn 154

Discovering New Therapies for AMD

May 13, 2019 The Molecular Ophthalmology Laboratory, under the direction of Dr. Karl Csaky, Managing & Medical Director at the Retina Foundation of the Southwest, is studying live cell cultures to investigate new potential drug treatments for age-related macular degeneration …

Front Door Picture For Page Next To Chairman Letter Edited

Retina Foundation Completes $3.7M Capital Campaign

April 8, 2019 The Retina Foundation of the Southwest acquired and renovated a new clinical research center in Dallas, Texas thanks to tremendous help from the Board of Directors and generous support from foundations, companies, and individuals. Join us at …

Rfsw Logo

Eight New Volunteers Join Board of Directors

April 1, 2019 The Retina Foundation of the Southwest is pleased to announce the on-boarding of eight new Board members, who recently joined 19 existing members to oversee our efforts and ensure that we are working efficiently to advance our …

10,000th Pediatric Patient (3.18.19)

Pediatric Lab Sees 10,000th Patient!

March 18, 2019 Since 1982, the Retina Foundation of the Southwest has been researching pediatric eye conditions to help infants and children with lazy eye, crossed eyes, cataracts, and other conditions. On March 18, 2019, our 10,000th patient completed his …

Rebion 3 Edited

Retina Foundation of the Southwest/Rebion Selected As “Partner of the Year”

November 8, 2018 The Retina Foundation of the Southwest and Rebion, a technology company in Boston, Massachusetts, created, evaluated, and received FDA approval for the Pediatric Vision Screener (PVS), a device that quickly and accurately evaluates the vision of children …